Cells treated with B-Raf siRNA demonstrated an ~50% reduction in infectivity in comparison to the control siRNA-treated cells, while C-Raf siRNA-treated cells demonstrated an ~80% reduction in infection (Figure 1A). The gene discussed is BRAF; the disease is infection.